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Abstract
The treatment of dental implants that increases surface area and roughness enhances 
bone-to-implant contact ratio; thus, facilitates the immediate loading of dental implants 
and fastens the osseointegration process. Structural and functional union of the implant 
with living bone is strongly infl uenced by the surface properties of the titanium (Ti) 
implants. As Ti and its alloys cannot directly bond with living bone, modifi cation of 
implant surface has been introduced to enhance osseointegration. The biological 
eﬀ ect of diﬀ erent methods of surface treatment has been studied in vivo and in vitro 
experiments. This review outlines the biological aspects and the use of certain surface 
modifi cations to control bone-to-implant biological response. In this review, we tried to 
cover a large number of reported studies related to implant surface treatments. Many of 
these treatments have been tried in the clinic and showed satisfactory results; therefore, 
specifi c recommendation regarding the best biocompatible implant surface treatment 
was hard to conclude.
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Introduction
Diﬀ erent treatments of dental implants that increase surface 
area and roughness enhance bone-to-implant contact (BIC) 
ratio and facilitate the immediate loading of dental implants and 
fasten the osseointegration process. Immediately after surgical 
implantation, the implant becomes surrounded by necrotic 
bone and blood clot. A cascade of events takes place at the bone-
implant interface begins with the interaction with water. Water 
molecules quickly bind to the implant surface, forming a mono 
or bilayer of water molecules.[1] The strength of water molecules 
binding is directly related to the wettability of the implant surface. 
Water molecules bind to hydrophilic surfaces stronger than 
hydrophobic surfaces. Titanium (Ti) and hydroxyapatite (HA) 
are the materials of choice owing to their relatively high degree 
of hydrophilicity.[2] The quantity and quality of bone formed 
around the implant are aﬀ ected by the implant surface properties. 
The composition and charges of implant surface are determinants 
for protein adsorption and cell attachment.[3] Hydrophilicity is 
aﬀ ected by the surface chemical composition where hydrophilic 
surfaces are favorable for the interactions with biological fl uids 
and cells when compared to the hydrophobic ones.[4,5]
Various methods of implant surface treatment have been 
studied to improve the biological surface properties, which favor 
the mechanism of osseointegration,[6] with faster and stronger bone 
formation, better stability is achieved during the healing process. 
Thus, more rapid loading of the implant is possible.[7] After the 
water overlayer has formed, natural ions, such as chloride (Cl−) 
and sodium (Na+) enter the interface and become incorporated 
into the water overlayer. Moreover, proteins originating from 
blood and tissue fl uids at the wound site, reach the surface and 
initially adsorb, desorb (native or denatured) or are replaced by 
larger proteins at a later stage. Living cells appear on the stage 
when this dynamic layer of protein forms.[1] Certain proteins are 
needed for cell anchorage, migration, and proliferation. Therefore, 
the composition of the adsorbed layer is a key mediator of cell 
behavior, determining which cells bind, how they bind and if 
they become activated. Hence, the required proteins, if correctly 
presented, can stimulate the formation of a newly organized 
tissue at the bone-implant interface.[2] The rapid adsorption of 
proteins determines the cell response to the composition of the 
underlying implant surface and subsequently the fate of implants; 
instead of a chronic infl ammatory response taking place or fi brous 
encapsulation to osseointegration or tissue regeneration.[2]
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Another objective can be achieved by implant surface 
modifi cations is to improve the clinical performance in areas 
with poor quantity/quality of bone, and stimulating bone 
growth in order to permit implant placement in sites that lack 
suﬃ  cient residual alveolar ridge.[8] The amount of BIC is an 
important determinant in the long-term success of dental 
implants. Maximizing the BIC, which is enhanced by implant 
surface roughness and osseointegration has become a goal 
of treatment.[9] In the metaphyses of the tibia and femur of 
mini pigs, implants with 6 diﬀ erent surface treatments were 
directly and morphometrically compared, after 3 and 6 weeks, 
with regard to BIC area.[4] Electro-polished and medium-grit-
blasted implant surfaces showed the lowest percentage of BIC 
area (20-25%). Large-grit-sandblasted and Ti plasma sprayed 
(TPS) implant surfaces had an average of 30-40% while large-
grit-sandblasted and acid-etched implant surfaces had an 
average of 50-60% and HA-coated implant surfaces showed 
the highest BIC area (60-70%). The authors concluded that 
“the extent of bone-implant interface was positively correlated 
with an increased roughness of the implant surface.” In this 
review, we will discuss the diﬀ erent biological reaction to certain 
dental implant surface treatments. Summary of advantages and 
disadvantages of diﬀ erent types of implant surface treatment is 
provided in Table 1.
Biological Response to Implants
At the initial stages of bone healing, devitalized bone is removed 
by osteoclasts. Osteogenic cells deposit a non-collagenous 
matrix layer, similar to bone cement line and lamina limitans, 
onto the resorbed surface of the bone.[10] This calcifi ed afi brillar 
layer, rich in calcium (Ca+2), phosphorus (P-), osteopontin and 
bone sialoprotein, forms on any kind of biomaterial implanted, 
and arises the possibility for optimal “bonding” between the 
pre-existent bone and the implant, as it is involved in osteoblast 
attachment.[11] After few days, osteoblasts starts depositing 
collagen matrix directly onto the early formed cement line, 
followed by the arrangement of the woven bone and developing 
bone trabeculae and marrow spaces. Therefore, it is thought that 
peri-implant osteogenesis starts from two directions: (i) Contact 
osteogenesis: From osteogenic cells, that were previously 
recruited to the implant surface and began secreting bone matrix, 
toward the pre-existing host bone, and (ii) distance osteogenesis: 
From the osteogenic cells, lining the remodeling borders of the 
pre-existent bone tissue, toward the implant surface.[12]
Implant Surface Roughness Techniques
Methods for roughening implant surface texture can be classifi ed 
into either additive or subtraction mechanisms. Additive 
mechanisms add particles on the biomaterial; create a surface with 
bumps, as in HA and other calcium phosphates (CaP) coatings, 
TPS and ion deposition implants. Subtraction mechanisms 
remove material from the implant surface; create pits or pores, 
as in mechanical or electro-polishing, grit blasting, acid etching, 
oxidation and grit blasting followed by acid etching.[13]
Depending on the dimension of the measured surface 
features, implant surface roughness is divided into macro, micro, 
and nanoroughness. Macro roughness comprises features in the 
range of millimeters to tens of microns. This scale directly relates 
to the implant geometry, with a threaded screw and macroporous 
surface treatments. It improves the primary implant fi xation and 
long-term stability. Thus, increases the mechanical interlocking 
between the macrorough features of the implant surface and 
the surrounding bone.[14,15] Microroughness is in the range of 
1-10 μm. It increases the interlocking between mineralized bone 
and implant surface. Some clinical evidences suggest that the 
micron-level surface topography results in the greater formation 
of bone at the implant surface.[16] Recently, surfaces provided 
with nanoscale topographies are widely used. Nanotechnology 
includes materials that have nano-sized topography or are 
composed of nanosized materials with a range of 1-100 nm. 
Nanometer roughness plays a role in the adsorption of proteins, 
adhesion of osteoblasts and the rate of osseointegration.[17]
Implants surface roughness can be created by common 
mechanical, chemical or physical methods. Mechanical methods 
include grinding, blasting, machining, sandblasting large 
grit acid etching (SLA) and polishing treatments. Chemical 
methods depend on chemical reactions occurring at the interface 
between Ti and a solution including acids or alkali, hydrogen 
peroxide, sol-gel, chemical vapor deposition, and anodization. 
Chemical surface modifi cation of Ti alters its surface roughness, 
composition and may improve its wettability and surface 
energy.[18] Physical methods include plasma spraying, sputtering 
and ion deposition. In the following paragraphs, we will focus 
on the biological responses related to the most commonly used 
methods of implant surface modifi cations.
Turned/machined (non-treated)
Studies on animal models and clinical studies have suggested a 
positive correlation between the implant surface roughness and 
BIC. The success rate of machined (non-treated) implants has 
been reported as less when placed in low bone density compared 
to good bone quality.[3,19] Osteoblasts are rugophilic; hence, they 
tend to grow along the grooves existing on the implant surface. 
The disadvantage regarding the morphology of non-treated 
implants is that they provide mechanical resistance for bone 
interlocking.[20]
Ultrastructural studies demonstrated the presence of an 
amorphous unmineralized or partly mineralized zone that 
separates the Ti surface from the bone and lacks collagen 
fi bers.[21] The rupture was reported to occur in the innermost 
of this zone by unscrewing during removal torque testing. 
The stability of threaded machined Ti implants was therefore 
believed to be due to a mechanical interlock with surface 
irregularities at the microscopic level and/or geometrical 
deviations at the macroscopic level.[22] Sennerby et al. studied the 
healing process in round screw-shaped machined Ti implants in 
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cortical bone after 3-180 days. They reported an early cellular 
response, a relative absence of infl ammatory cells and a rapid 
formation of woven bone from the endosteal surface. 7 days 
after implantation, solitary bone formation was observed in the 
threads and at the endosteal surface of the cortical bone. With 
time, both types of woven bone fused and increasingly fi lled the 
implant threads. The increased bone-Ti surface contact was thus 
a result of ingrowth of bone from the surroundings and did not 
start at the implant surface.[21]
Acid etched
Acid etched implant surface produces a micro texture rather than 
a macro texture. The dual acid etched (DAE) surfaces improve 
the osteoconductive process through the attachment of fi brin 
and osteogenic cells, enhancing bone formation directly on the 
implant surface.[23,24] When a higher temperature is used with an 
acid etching method, they produce a homogeneous microporous 
surface with increased cell adhesion and greater BIC compared 
to TPS surfaces.[8]
The increased surface wettability was suggested to promote 
fi brin adhesion, which provides contact guidance for the 
osteoblasts migrating along the implant surface.[4] In addition, 
expression of platelet and extracellular genes promote the 
colonization of osteoblasts on implant surface and improves 
osseointegration. Experimental studies reported that DAE 
implants have shown greater BIC and less bone resorption 
compared to machined implants.[25,26]
Hydrophilic SLA alters human gingival fi broblast adhesion 
and the intracellular localization of extracellular signal-
regulated kinase ½.[27] In vitro reports,[28-30] on cell response to 
hydrophilic SLA, osteoblasts behavior was aﬀ ected by altering 
protein absorption that directly induced diﬀ erentiation by 
the assembly of focal adhesion sites (FAs) and intracellular 
Table 1: Summery of advantages and disadvantages of diff erent types of implant surface treatments
Implant surface treatment Advantages Disadvantages
• Turned/machined • Bone interlocking • Macro rather than micro roughness
• Increased bone-Ti surface contact
•  Bone ingrowth from surroundings and did not start at 
implant surface
• Acid etched •  Homogeneous microporous surface with increased 
cell adhesion and greater BIC compared to TPS 
surfaces
•  Increased surface wettability promotes fi brin 
adhesion, which provides contact guidance for 
osteoblasts migration along implant surface
• Stochastic surface characteristics
• Not 3D
• Laser sintering • Forms complex (3D) geometry
• Allows better osteoconductive process
• CaP coating • Precipitation of a biological apatite onto implant 
surface
• Early biological fi xation of implants
•  Established positive bone-to-implant healing eff ect of 
CaP ceramic coatings
•  Did not diff er in osteoporotic and non-osteoporotic 
healthy animal models
• HA coating • Bioactive
• Direct strong bone-to-implant bond
• Growth factors coating •  Bio-adhesive motif, binds to adhesion receptors and 
promotes cell adhesion
• BMPs, can induce new bone formation
•  BIC and osteoblast diff erentiation were not improved by 
RGD application
•  Functionalization success depends on type, delivery and 
concentration of coating material
•  Electrochemical 
anodization
•  Ca+2 and P− enrichment of anodized surface helps to 
produce a chemical bond with the implant
• Osteoconductive potential
• Fluoride treatment • Improved osteoblastic diff erentiation
•  Sustained greater push-out forces and showed higher 
removal torque
•  Decreased cell proliferation occurred aft er 7 days on F 
treated implants
•  Biologically active 
drugs coating
• Bioactive
• Possibility to add an antibacterial eff ect
• Not commercially available
• TPS • Roughness of 7 μ can increase implant surface area • Similar pullout strength to HA implants
• Lower bone contact length on TPS surface compared to HA
• Alkali treatment • Bioactive • Not commercially available
TPS: Titanium plasma sprayed, HA: Hydroxyapatite, BMP: Bone morphogenetic proteins, CaP: Calcium phosphates
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signaling cascade activation.[28] The FAs are important sites 
of signaling that control spreading, migration, cytoskeletal 
organization, cell cycle progression, gene expression and matrix 
fi brillogenesis.[31-33]
Laser sintering
Previous studies showed that direct laser fabrication (DLF) 
implants have structures with complex geometry and could 
allow the better osteoconductive process. Evaluation of 
cytocompatibility and fi brin clot extension was carried out using 
osteoblasts and human blood to compare cell growth and fi brin 
clot covered areas on several implant surfaces. DLF implant 
surface showed lower cell density compared to machined, 
smooth textured grit blasted, and acid-etched implant surfaces. 
Inorganic acid etching slightly improved the extension of human 
blood to increase the micro roughness. Moreover, laser metal 
sintered implants were better adapted to the elastic properties 
of bone. Thereby, DFL implants could decrease stress-shielding 
eﬀ ects and enhance implant long-term success rates.[34,35]
Laser-sintered Ti implants showed high purity with enough 
roughness for good osseointegration compared to other 
treatments.[36] Biological evaluation of the role of Ti ablation 
and chemical properties showed the ability of its grooved surface 
to orientate osteoblasts attachment and control the direction 
of ingrowth.[37] We designed a clinical study to evaluate laser-
sintered one-piece implants (OPI) placed in the mandibular 
premolar area and subjected to early loading after 3 weeks of 
initial placement. In this study, we reported satisfactory results 
based on clinical and radiographic evaluation for 1 year of follow-
up and stated that laser-sintered early-loaded OPI is a good 
alternative to the two-piece machined implants.[38]
CaP coating
Coating of dental Ti implants with CaP ceramic is commonly 
used to change the chemical composition of the implant 
surface.[12] After implant placement, the CaP particles are released 
into the peri-implant region; raising the saturation of body fl uids 
and leading to the precipitation of a biological apatite onto the 
implant surface.[39,40] Endogenous proteins present in this layer 
of biological apatite act as a matrix for osteogenic cell attachment 
and growth.[11] Integrins mediate the cellular interactions with 
the apatite layer and its proteins onto the implant surface. The 
signaling pathways via integrins can regulate bone forming cell 
activity.[38,39] The bone stimulating action of CaP coatings at 
implant surface enhances early osseointegration compared to 
non-CaP coated dental implants.[41] The biological fi xation of 
Ti implants coated with CaP to bone tissue takes place earlier 
compared to non-CaP coated implants.[42] Therefore, CaP 
ceramic-coated implants have been suggested for osteoporotic 
bone to compensate for low bone quantity/density and for 
impaired or delayed bone regeneration.[43-46] The established 
positive bone-to-implant healing eﬀ ect of CaP ceramic coatings 
did not diﬀ er in osteoporotic and non-osteoporotic healthy 
animal models.[47]
HA coating
Several methods have been used for applying HA coatings 
onto metals, and each method can result in diﬀ erent material 
properties. Plasma spraying that forms a coating thickness 
of 40-50 μm is the most common used technique for coating 
Ti implants. A synthetic form of HA has a similar chemical 
composition to the mineral matrix of bone.[48] HA can form 
a direct and strong bone-to-implant bond. After implant 
placement, HA acts as a bioactive material where a sequence of 
events results in precipitation of a CaP rich layer on the implant 
surface through a solid solution ion exchange at the implant-
bone interface. The CaP incorporated layer will be developed 
in a biologically equivalent HA that will be incorporated in the 
developing bone through octacalcium phosphate.[49]
The inorganic phase in bone tissue is mainly composed of 
carbonate-rich HA. HA ceramics has been an obvious candidate 
for deposition as a coating onto bone implant surfaces. These 
HA coatings were proved to be bioactive and stimulate the 
formation of new bone tissue. In many preclinical and clinical 
studies calcium-to-phosphate ratio, phase composition and 
crystal structure, are used as chemical parameters, to optimize 
the performance of CaP coatings.[50] HA coatings showed a 
persistent signifi cant improvement of the osteoconductivity of 
metallic implants.[51-53] During the past two decades, recent trends 
in research on CaP coatings mainly focused on modifi cation of 
its chemical structure and addition of ionic dopants. Recently, 
several types of CaP-based coatings have been explored such as 
pure HA, Silicon-containing HA,[54] strontium-doped HA,[55] 
magnesium-substituted HA,[56] bisphosphonate and HA,[57] 
carbonated HA,[58] fl uorinated HA,[59] and antibacterial silver-
containing HA.[60]
Growth factors coating
Implant surfaces can be coated with biomolecules, such as; bio-
adhesive motifs or growth factors, to promote osseointegration. 
The RGD sequence from fi bronectin is the most common 
used bio-adhesive motif that binds to adhesion receptors and 
promotes cell adhesion.[61] RGD functionalized and tissue-
engineered constructs can improve early bone ingrowth and 
matrix mineralization in vivo.[62,63]
Nowadays, numerous materials have been RGD 
functionalized for medical applications. However, BIC and 
osteoblast diﬀ erentiation were not improved by RGD application 
to Ti implant surfaces.[64,65] This might be due to the absence of 
crucial modulatory domains from the native fi bronectin; the 
RGD signals disappear by non-specifi c adsorption of plasma 
protein and interactions with infl ammatory components.[66] On 
the other hand, Germanier et al. compared sandblasted implant 
surfaces that were either RGD peptide polymer coated or 
uncoated and placed in the maxillae of minipigs. They concluded 
that RGD coating might enhance bone apposition at the early 
stages of bone regeneration.[67]
Bone morphogenetic proteins (BMPs) that can induce new 
bone formation,[68] are the only growth factors that have such 
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eﬀ ect in extraskeletal sites; BMPs induce the diﬀ erentiation of 
cells derived from soft tissues into bone forming cells.[69] BMP-2 
can promote re-osseointegration of peri-implant defects. In 
non-human primates, peri-implant defect made over 11 months 
in HA coated implant, and BMP-2 was placed using collagen 
sponge carrier. Histomorphometric analysis after 16 months 
showed that the vertical bone healing in BMP-2 treated 
implants is equal to three folds that of the untreated.[70] Liu et al. 
compared the eﬀ ects of BMP-2 and its mode of delivery on the 
osteoconductivity of dental implants with either a machined 
or a CaP-coated Ti surface in the maxillae of minipigs. The 
bone volume formed after 3 weeks within the osteoconductive 
space (peri-implant) was highest for CaP-coated and uncoated 
implants with no BMP-2, while was the lowest for adsorbed 
BMP-2 CaP-coated implants. Hence, the osteoconductivity 
of functionalized implant surfaces was aﬀ ected by the method 
of BMP-2 delivery, being impaired when BMP-2 is present 
as a superfi cially adsorbed depot on CaP-coated or uncoated 
surfaces.[71] Wikesjo et al. studied osseointegration and vertical 
bone formation by recombinant human BMP-2 (rhBMP-2) 
coated onto a Ti porous oxide implant surface. A critical size, 
5 mm, supra-alveolar peri-implant defects were created and 
implants coated with rhBMP-2 at 0.75 or 1.5 or 3.0 mg/mL or 
uncoated controls were installed and compared. New bone was 
formed with characteristics of the adjoining resident Type II 
bone including cortex formation at rhBMP-2 coated implant 
sites with the concentration of 0.75 or 1.5 mg/mL. However, 
sites coated with rhBMP-2 at 3.0 mg/mL concentration showed 
more immature trabecular bone formation and peri-implant 
bone remodeling that resulted in implant displacement.[72] The 
rhBMP-2 coated Ti porous oxide implants induced clinically 
more local bone formation in vertical ridge augmentation 
and osseointegration, but higher rhBMP-2 concentrations 
were accompanied with negative eﬀ ects.[73] Therefore, the 
success of functionalization depends on the type, delivery and 
concentration of the coating material.
Platelet-derived growth factor (PDGF) and insulin-like 
growth factor (IGF) were used in combination around implants 
where they can produce 2-3 times more new bone within 7 days 
compared to controls. However, after 21 days, in spite of a large 
volume of new bone formed around dental implants treated 
with growth factors, there was no signifi cant diﬀ erence between 
growth factor and control sites. Thus, the use of PDGF/IGF may 
only accelerate the process of bone formation.[74]
Electrochemical anodization
The electrochemical anodization can produce a mixed 
nano/submicron scale Ti oxide (TiO2) network layer (lateral 
pore size: 20-160 nm) on a polished Ti surface in 10 min. This 
TiO2 network layer improved the whole blood coagulation and 
human bone marrow stem cell adhesion on a Ti dental implant 
surface.[75] The galvanic anodization of Ti in strong acids 
produces a thick layer of TiO2. Some researchers think that Ca
+2 
and P- enrichment of the anodized surface helps to produce a 
chemical bond between the implant and the peri-implant bone, 
leading to a higher bone-to-implant interfacial shear strength.[76,77] 
Burgos et al. compared implant surface manufactured by anodic 
oxidation to turned surfaces in a rabbit model. BIC values were 
20%, 23%, and 46% around the oxidized surfaces with a diﬀ erent 
osseointegration pattern, while 15%, 11%, and 26% around 
the machined surfaces, after 7, 14 and 28 days, respectively.[78] 
Huang et al. studied the oxidized implant surfaces placed in the 
posterior maxilla of monkeys. After 16 weeks, the recorded mean 
of BIC was 74%. They stated that this oxidized surface showed a 
considerable osteoconductive potential resulting in a high level 
of implant osseointegration in Type IV bone.[79]
Fluoride treatment
Ti can react to fl uoride (F) ions, forming soluble TiF4 that 
enhances osseointegration of dental implants. The analysis 
of human mesenchymal cells showed no diﬀ erence in cell 
attachment between the F treated and control (grit-blasted) 
implants. However, decreased cell proliferation occurred 
after 7 days on F treated implants compared to controls. This 
chemical surface treatment improved osteoblastic diﬀ erentiation 
in comparison to control implants. Fluoridated implants also 
sustained greater push-out forces and showed higher removal 
torque than control implants.[80] In addition, it increased 
osteoblast diﬀ erentiation represented by increased expression of 
Cbfa1, osterix, and bone sialoprotein.[81]
Biologically active drugs coating
Bisphosphonate coated Ti implants improved local bone 
density in the peri-implant region,[82] due to its anti-resorptive 
eﬀ ect limited to the implant site. Du et al. studied the eﬀ ect of 
simvastatin, by oral administration, on implant osseointegration 
in osteoporotic rats and showed that it can enhance implant 
osseointegration.[83] Intraperitoneal administration of 
simvastatin increased BIC ratio and bone density and might have 
the potential to enhance osseointegration.[84] Yang et al. reported 
that simvastatin loaded porous implant surfaces accelerated 
osteogenic diﬀ erentiation of preosteoblasts, which can enhance 
the process of osseointegration.[85]
Coating implants with antibacterial substances provides an 
antibacterial property to the implant itself. Tetracycline-HCl 
has the ability to kill microorganisms that may contaminate the 
implant surface and can remove the smear layer and endotoxins 
from the implant surface. In addition, it prevented the action of 
collagenase, increased cell proliferation, attachment, and bone 
healing, improved blood clot attachment and retention on the 
implant surface during the early phase of healing, thus enhanced 
osseointegration.[86]
TPS
This method includes injecting Ti powder into a plasma torch 
at high temperature. Ti particles condense and fuse together 
forming TPS coating with a mean roughness of 7 μm that 
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increases the implant surface area. Al-Nawas et al. compared 
diﬀ erent types of macro and micro structure implant surfaces in 
dogs. After 8 weeks of healing and 3 months of loading, higher 
BIC values of TPS rough surfaces and blasted/acid-etched 
implants were reported in comparison to machined ones. 
The diﬀ erence between the TPS and the blasted/acid-etched 
implants BIC values was not signifi cant.[87] In rabbits, Klokkevold 
et al. evaluated the torque resistance to removing screw shaped 
Ti implants that were with either DAE or machined, or TPS 
surface; TPS surface exhibited a signifi cantly more complex 
surface topography.[88] An in vivo study that evaluated TPS versus 
plasma sprayed HA implants, showed that bone contact length 
for HA implants was signifi cantly higher than TPS at 12 weeks of 
implant placement and 1 year of loading. TPS implants showed 
similar pull out strength compared to the HA implants. The 
lower bone contact length on TPS surface compared to HA 
surfaces had no eﬀ ect on the bone-to-implant strength in both 
implant types.[89]
Alkali treatment
NaOH treatment includes the formation of a bioactive 
sodium titanate layer on orthopedic Ti surfaces. Following the 
immersion in stimulated body fl uids (SBF), bone-like apatite 
is deposited onto this layer.[90] Sodium ions in the titanate layer 
are exchanged with H3O+ ions from the SBF forming Ti-OH 
groups, which combine with Ca+2 ions to produce amorphous 
calcium titanate. The reaction with phosphate polyatomic 
ions forms amorphous CaP, which transforms into bone-like 
apatite.[91] Alkali treatment and biomimetic precipitation of CaP 
coatings are techniques that can be used to coat the interior of 
porous metallic surfaces.[92-94]
Conclusions
In addition to surface roughness treatments, surface chemistry 
manipulation of the porous implant surface, further enhances 
osseointegration and strengthens BIC. Biological bone reactions 
to most implant surface treatments were satisfactory. Studies on 
the development of osteogenic implant surface favor immediate 
or early loading of dental implants. In this review, we tried to 
cover a large number of reported studies related to implant 
surface treatments. However, it is hard to identify the best type 
of surface treatment based on the biocompatibility of treated 
implant surface.
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